Shelly Skidelsky - Multiple Sclerosis and CIDP Stem Cell Patient

Shelly has multiple sclerosis (MS) and chronic inflammatory demyelenating poly-neuropathy (CIDP). He received adult stem cell treatment in 2008 to treat symptoms of the conditions.

Improvement statistics

Based on follow-up reports from 27 patients across 60 forms, here is the percentage who self-reported any improvement after treatment.

83%
Movement in general
reported improvement · N=6
83%
Limb muscle strength
reported improvement · N=6
67%
Hand control
reported improvement · N=6
67%
Overall strength
reported improvement · N=6
60%
Swallowing
reported improvement · N=10
55%
Speaking
reported improvement · N=11
47%
Urinary incontinence
reported improvement · N=15
46%
Loss of sensitivity
reported improvement · N=11
44%
Cognitive impairment
reported improvement · N=9
43%
Numbness
reported improvement · N=14

About this data

Patients self-assess each symptom on a 5-point scale (Worse / No improvement / Small / Moderate / Significant) at follow-up checkpoints after treatment, comparing to their pre-treatment baseline. "Reported improvement" combines the small, moderate and significant buckets. Data is updated daily from our internal patient registry. As with any medical treatment, past results do not guarantee future outcomes — improvements vary from patient to patient.

Internationally accredited

Held to global laboratory and biologics standards.